Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Prokidney Corp (PROK)

Prokidney Corp (PROK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 527,491
  • Shares Outstanding, K 229,344
  • Annual Sales, $ 0 K
  • Annual Income, $ -35,470 K
  • 60-Month Beta 1.08
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PROK with:

Options Overview Details

View History
  • Implied Volatility 138.32% ( -158.11%)
  • Historical Volatility 175.13%
  • IV Percentile 40%
  • IV Rank 14.14%
  • IV High 917.73% on 12/18/23
  • IV Low 9.97% on 10/17/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 92
  • Volume Avg (30-Day) 154
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 794
  • Open Int (30-Day) 725

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.25
  • Number of Estimates 1
  • High Estimate -0.25
  • Low Estimate -0.25
  • Prior Year -0.16
  • Growth Rate Est. (year over year) -56.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.41 +53.40%
on 04/05/24
3.37 -35.91%
on 04/17/24
+0.52 (+31.71%)
since 03/28/24
3-Month
1.18 +83.05%
on 02/13/24
3.37 -35.91%
on 04/17/24
+0.76 (+54.29%)
since 01/30/24
52-Week
1.12 +92.86%
on 11/17/23
13.51 -84.01%
on 08/11/23
-7.28 (-77.12%)
since 04/28/23

Most Recent Stories

More News
Why Shares of ProKidney Were Dropping Thursday

Two factors led to the stock's slide on Thursday.

PROK : 2.18 (-5.22%)
Pre-Market Brief: Stocks Mostly Higher As Investors Await U.S. Inflation Data

March S&P 500 futures (ESH23) are trending up +0.32% this morning after three major U.S. benchmark indices finished the regular session higher as market participants awaited U.S. inflation data for further...

ESH23 : 3,957.05s (-0.09%)
JD-.LN : 115.600 (-0.86%)
HEPA : 1.4000 (+2.19%)
BWEN : 2.16 (-2.26%)
PROK : 2.18 (-5.22%)
CONN : 3.53 (-4.85%)
SHC : 11.27 (-0.97%)
STM : 40.02 (-2.82%)
Did This News Just Mark the End of the SPAC Boom?

The most prolific SPAC sponsor just made a big announcement.

LCID : 2.56 (+2.40%)
DKNG : 42.15 (-1.47%)
SPCE : 0.8791 (-0.54%)
OPEN : 2.05 (-3.30%)
CLOV : 0.6496 (-3.63%)
SOFI : 6.82 (-3.26%)
PROK : 2.18 (-5.22%)
AKLI : 0.3970 (+69.01%)
IPOD : 10.03 (-0.10%)
IPOF : 10.03 (unch)
ProKidney Strengthens Board of Directors with Appointments of Dr. John M. Maraganore and Jennifer Fox

Maraganore brings more than 35 years of scientific, research and development, capital markets and managerial leadership expertise to ProKidney Fox joins...

PROK : 2.18 (-5.22%)
ProKidney Appoints Kerry Cooper, M.D., as Senior Vice President of Medical Affairs

Extensive Nephrology Medical Affairs Leadership and Clinical Practice Expertise Brought to ProKidney...

PROK : 2.18 (-5.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

ProKidney LP is a late clinical-stage cellular therapeutics company focused on CKD. The company's lead product candidate includes REACT(TM) is a first-of-its-kind, patented disease-modifying autologous cellular therapy. ProKidney LP, formerly known as Suvretta Holdings Corp. III, is based in WINSTON-SALEM,...

See More

Key Turning Points

3rd Resistance Point 2.75
2nd Resistance Point 2.61
1st Resistance Point 2.45
Last Price 2.18
1st Support Level 2.15
2nd Support Level 2.01
3rd Support Level 1.85

See More

52-Week High 13.51
Fibonacci 61.8% 8.78
Fibonacci 50% 7.32
Fibonacci 38.2% 5.85
Last Price 2.18
52-Week Low 1.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar